Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Pataday Ophthalmic Solution, 0.2%, of Novartis Pharmaceuticals Corporation.

from India Infoline News Service http://bit.ly/2Y1Fl14